日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

低剂量皮下或静脉注射单克隆抗体预防疟疾

Wu, Richard L; Idris, Azza H; Berkowitz, Nina M; Happe, Myra; Gaudinski, Martin R; Buettner, Christian; Strom, Larisa; Awan, Seemal F; Holman, LaSonji A; Mendoza, Floreliz; Gordon, Ingelise J; Hu, Zonghui; Campos Chagas, Andrezza; Wang, Lawrence T; Da Silva Pereira, Lais; Francica, Joseph R; Kisalu, Neville K; Flynn, Barbara J; Shi, Wei; Kong, Wing-Pui; O'Connell, Sarah; Plummer, Sarah H; Beck, Allison; McDermott, Adrian; Narpala, Sandeep R; Serebryannyy, Leonid; Castro, Mike; Silva, Rosa; Imam, Marjaan; Pittman, Iris; Hickman, Somia P; McDougal, Andrew J; Lukoskie, Ashly E; Murphy, Jittawadee R; Gall, Jason G; Carlton, Kevin; Morgan, Patricia; Seo, Ellie; Stein, Judy A; Vazquez, Sandra; Telscher, Shinyi; Capparelli, Edmund V; Coates, Emily E; Mascola, John R; Ledgerwood, Julie E; Dropulic, Lesia K; Seder, Robert A

A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965

使用单羧化酶转运体 1 抑制剂 AZD3965 治疗后出现恶性高乳酸血症酸中毒的病例报告

McNeillis, Rosie; Greystoke, Alastair; Walton, Jon; Bacon, Chris; Keun, Hector; Siskos, Alexandros; Petrides, George; Leech, Nicola; Jenkinson, Fiona; Bowron, Ann; Halford, Sarah; Plummer, Ruth

Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial

编码埃博拉病毒和马尔堡病毒野生型糖蛋白的 DNA 疫苗在 I 期临床试验中的安全性和免疫原性

Uzma N Sarwar, Pamela Costner, Mary E Enama, Nina Berkowitz, Zonghui Hu, Cynthia S Hendel, Sandra Sitar, Sarah Plummer, Sabue Mulangu, Robert T Bailer, Richard A Koup, John R Mascola, Gary J Nabel, Nancy J Sullivan, Barney S Graham, Julie E Ledgerwood; VRC 206 Study Team